SEC Comment Letter 0000000000-24-012298 to FIRST SOLAR, INC. (FSLR) (CIK 0001274494)
FIRST SOLAR, INC. (FSLR) (CIK 0001274494)
Date: Nov. 5, 2024 · CIK: 0001274494 · Accession: 0000000000-24-012298
AI Filing Summary & Sentiment
File numbers found in text: 001-33156
Show Raw Text
November 5, 2024
Alexander Bradley
Chief Financial Officer
First Solar, Inc.
350 West Washington Street, Suite 600
Tempe, Arizona 85288
Re:First Solar, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2023
Filed February 27, 2024
Form 10-Q for the Fiscal Quarter Ended September 30, 2024
Filed October 29, 2024
File No. 001-33156
Dear Alexander Bradley:
We have limited our review of your filing to the financial statements and related
disclosures and have the following comment.
Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this letter, we may have additional comments.
Form 10-Q for the Fiscal Quarter Ended September 30, 2024
Condensed Consolidated Financial Statements
10. Commitments and Contingencies
Product Warranties, page 23
We note you identified manufacturing issues affecting certain Series 7 modules
manufactured in 2023 and 2024 that may cause the modules to experience premature
power loss once installed in the field and that, based on currently available
information and certain assumptions and estimates, you believe a reasonable estimate
of aggregate losses related to these manufacturing issues will range from
approximately $50 million to $100 million. We also note as of September 30, 2024,
you increased your product warranty liability by the low end of the range, which you
recorded as a reduction to revenue. Please address the following:
More fully explain your basis for recording the increase in your product warranty •1.
November 5, 2024
Page 2
liability that resulted from this change in estimate as a reduction to revenue and
explain where and how prior period changes in estimates were recorded as well as
where and how product warranties are recorded when products are sold. Address
the apparent inconsistency between recording the current period increase as a
reduction to revenue with disclosures in MD&A that indicate “cost of sales also
includes depreciation of manufacturing plant and equipment, facility-related
expenses, environmental health and safety costs, and costs associated with
shipping, warranties , and solar module collection and recycling”.
•More fully explain how you determined the range of reasonably possible losses
noted above, including the material underlying assumptions. Revise future filings
to disclose and discuss the facts and circumstances related to this change in
estimate and the material assumptions underlying it and provide a sensitivity
analysis to disclose the potential impact that changes in these assumptions could
have on your financial statements under Critical Accounting Estimates in MD&A.
Revise future filings to also address the expected timeframe over which the
additional information related to these manufacturing issues are expected to
become available that could result in changes in this estimate related to the
product warranty liability.
In closing, we remind you that the company and its management are responsible for
the accuracy and adequacy of their disclosures, notwithstanding any review, comments,
action or absence of action by the staff.
Please contact Dale Welcome at 202-551-3865 or Anne McConnell at 202-551-3709
with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing